Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Niloofar Momenzadeh"'
Autor:
Mohsen Mohammadi, Gholamreza Khamisipour, Faezeh Soltanpour, Fatemeh Omrani, Behrooz Taheri, Niloofar Momenzadeh, Moradali Fouladvand
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 19, Iss 3 (2020)
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallergic patients to the Chenopodiaceae family. Therefore, the present study was conducted to develop a hypoallergenic Che a 3 derivatives as the candidate
Externí odkaz:
https://doaj.org/article/e9ea8d787a8049ba8f6fcb4573e56cb2
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212759 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0206578.].
Externí odkaz:
https://doaj.org/article/cfa0f4029b7c40b693ffc8bb977a2361
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0206578 (2018)
BACKGROUND:The global crisis of antibiotic resistance increases the demand for the new promising alternative drugs such as antimicrobial peptides (AMPs). Accordingly, we have described a new, previously unrecognized effective AMP, named dicentracin-l
Externí odkaz:
https://doaj.org/article/b05b4594706b4a78a0559c84962466a7
Publikováno v:
International Journal of Peptide Research and Therapeutics. 27:2391-2401
Breast cancer is one of the well-known non-cutaneous cancers among women worldwide. In the present study, we have characterized the anti-cancer activity of Moronecidin-like peptide derived from the Hippocampus comes in comparison with a well-known an
Autor:
Fatemeh Omrani, Javad Akhtari, Mohsen Mohammadi, Parva Dehghani, Afshar Bargahi, Khashayar Hesamizadeh, Samad Akbarzadeh, Afshin Shirkani, Maryam Zamani Sani, Iraj Nabipour, Niloofar Momenzadeh, Soheila J. Maleki, Sahel Heidari, Maryam Vakili Moghadam
Publikováno v:
Applied Microbiology and Biotechnology. 105:77-91
Chimeric virus-like particles (VLPs) were developed as a candidate for allergen-specific immunotherapy. In this study, hepatitis B core antigen (HBcAg) that genetically fused to Chenopodium album polcalcin (Che a 3)-derived peptide was expressed in E
Autor:
Faezeh Soltanpour, Gholamreza Khamisipour, Mohsen Mohammadi, Niloofar Momenzadeh, Fatemeh Omrani, Behrooz Taheri, Moradali Fouladvand
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 19, Iss 3 (2020)
Chenopodium album polcalcin (Che a 3) is characterized as a major cause of cross-reactivity inallergic patients to the Chenopodiaceae family. Therefore, the present study was conducted to develop a hypoallergenic Che a 3 derivatives as the candidate
Autor:
Parva Dehghani, Sadegh Darvishi, Niloofar Momenzadeh, Behrouz Taheri, Mohsen Mohammadi, Sobhan Hajian, Mona Roozbehani, Jebreil Shamseddin, Zahra Farshadzadeh
Publikováno v:
Infection and Drug Resistance
Behrouz Taheri,1,2 Mohsen Mohammadi,3 Niloofar Momenzadeh,3 Zahra Farshadzadeh,2,4 Mona Roozbehani,5 Parva Dehghani,3 Sobhan Hajian,6 Sadegh Darvishi,6 Jebreil Shamseddin71Department of Medical Laboratory Sciences, School of Paramedicine, Ahvaz Jundi
Autor:
Reza Salarinia, Behrouz Taheri, Afshar Bargahi, Zahra Farshadzadeh, Niloofar Momenzadeh, Mohsen Mohammadi, Iraj Nabipour
Publikováno v:
Marine biotechnology (New York, N.Y.). 20(6)
Antimicrobial peptides (AMPs) have attracted attentions as a novel antimicrobial agent because of their unique activity against microbes. In the present study, we described a new, previously unreported AMP, moronecidin-like peptide, from Hippocampus
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0206578 (2018)
PLoS ONE
PLoS ONE
Background The global crisis of antibiotic resistance increases the demand for the new promising alternative drugs such as antimicrobial peptides (AMPs). Accordingly, we have described a new, previously unrecognized effective AMP, named dicentracin-l